enzalutamide

English

Etymology

From (b)enza(mide) +‎ -lutamide (“nonsteroid antiandrogen”).

Noun

enzalutamide (uncountable)

1. (pharmacology) A synthetic, non-steroidal pure antiandrogen developed for the treatment of metastatic castration-resistant prostate cancer.
   • 2015 July 16, “Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor”, in PLOS ONE‎^[1], →DOI:

     Abiraterone and enzalutamide are newly approved drugs for CRPC patients; although, patients will still eventually relapse and the overall survival is prolonged only ~4–5 months after treatment with the AR signaling becoming active in most of these relapsed tumors.